46 related articles for article (PubMed ID: 12968131)
1. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
Caberlotto L; Rimondini R; Hansson A; Eriksson S; Heilig M
Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131
[TBL] [Abstract][Full Text] [Related]
2. Activation of specific neuronal circuits by corticotropin releasing hormone as indicated by c-fos expression and glucose metabolism.
Dubé T; Brunson T; Nehlig A; Baram TZ
J Cereb Blood Flow Metab; 2000 Oct; 20(10):1414-24. PubMed ID: 11043904
[TBL] [Abstract][Full Text] [Related]
3. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat.
Caldji C; Tannenbaum B; Sharma S; Francis D; Plotsky PM; Meaney MJ
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5335-40. PubMed ID: 9560276
[TBL] [Abstract][Full Text] [Related]
4. Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.
Brewer AL; Felter CE; Sternitzky AR; Spencer SM
Pharmacol Biochem Behav; 2024 Mar; 236():173707. PubMed ID: 38244864
[TBL] [Abstract][Full Text] [Related]
5. French medicine regulator bans two cannabinoid derivatives after reported side effects.
Casassus B
BMJ; 2024 Jun; 385():q1249. PubMed ID: 38843900
[No Abstract] [Full Text] [Related]
6. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation.
Nishiyama M; Makino S; Iwasaki Y; Tanaka Y; Nazarloo HP; Kaneda T; Asaba K; Hashimoto K
Brain Res; 2008 Sep; 1228():107-12. PubMed ID: 18619422
[TBL] [Abstract][Full Text] [Related]
7. Sleep disturbance after cessation of cannabis administration in mice.
Asano T; Takemoto H; Horita T; Tokutake T; Izuo N; Mochizuki T; Nitta A
Neuropsychopharmacol Rep; 2023 Dec; 43(4):505-512. PubMed ID: 36905178
[TBL] [Abstract][Full Text] [Related]
8. Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.
Serrano A; Pavon FJ; Buczynski MW; Schlosburg J; Natividad LA; Polis IY; Stouffer DG; Zorrilla EP; Roberto M; Cravatt BF; Martin-Fardon R; Rodriguez de Fonseca F; Parsons LH
Neuropsychopharmacology; 2018 Aug; 43(9):1840-1850. PubMed ID: 29748627
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.
Roberto M; Spierling SR; Kirson D; Zorrilla EP
Int Rev Neurobiol; 2017; 136():5-51. PubMed ID: 29056155
[TBL] [Abstract][Full Text] [Related]
10. Keep off the grass? Cannabis, cognition and addiction.
Curran HV; Freeman TP; Mokrysz C; Lewis DA; Morgan CJ; Parsons LH
Nat Rev Neurosci; 2016 May; 17(5):293-306. PubMed ID: 27052382
[TBL] [Abstract][Full Text] [Related]
11. Substance use modulates stress reactivity: Behavioral and physiological outcomes.
Fosnocht AQ; Briand LA
Physiol Behav; 2016 Nov; 166():32-42. PubMed ID: 26907955
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
13. Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.
Irimia C; Polis IY; Stouffer D; Parsons LH
Psychopharmacology (Berl); 2015 Aug; 232(16):3033-43. PubMed ID: 25925779
[TBL] [Abstract][Full Text] [Related]
14. Stress is a principal factor that promotes tobacco use in females.
Torres OV; O'Dell LE
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():260-8. PubMed ID: 25912856
[TBL] [Abstract][Full Text] [Related]
15. Obesity and addiction: neurobiological overlaps.
Volkow ND; Wang GJ; Tomasi D; Baler RD
Obes Rev; 2013 Jan; 14(1):2-18. PubMed ID: 23016694
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety.
Harte-Hargrove LC; Dow-Edwards DL
Behav Brain Res; 2012 May; 231(1):48-59. PubMed ID: 22421367
[TBL] [Abstract][Full Text] [Related]
17. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
Logrip ML; Koob GF; Zorrilla EP
CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881
[TBL] [Abstract][Full Text] [Related]
18. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
Koob GF; Zorrilla EP
Curr Opin Investig Drugs; 2010 Jan; 11(1):63-71. PubMed ID: 20047160
[TBL] [Abstract][Full Text] [Related]
19. HU210-induced downregulation in cannabinoid CB1 receptor binding strongly correlates with body weight loss in the adult rat.
Dalton VS; Wang H; Zavitsanou K
Neurochem Res; 2009 Jul; 34(7):1343-53. PubMed ID: 19169813
[TBL] [Abstract][Full Text] [Related]
20. Stress-related factors in cannabis use and misuse: implications for prevention and treatment.
Hyman SM; Sinha R
J Subst Abuse Treat; 2009 Jun; 36(4):400-13. PubMed ID: 19004601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
